1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Cefadroxil: new trials by email Literature Review of Cefadroxil trials Research Report on Cefadroxil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy | Phase 2 | Recruiting | Massachusetts General Hospital | 300 | 2025-05-05 | 2026-09-04 |
| Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers Faropenem, Amoxicillin/clavulanic acid, Cefadroxil - Pulmonary Tuberculosis | Phase 2 | Completed | National University Hospital, Singapore | 58 | 2019-02-11 | 2020-03-23 |
Anaphylaxis (1) · Drug Hypersensitivity (1) · Hypersensitivity (1) · Tuberculosis, Pulmonary (1)
Massachusetts General Hospital (1) · National University Hospital, Singapore (1)
Philippines (1) · Singapore (1) · Uganda (1) · United States (1)
David A Khan, MD (1) · Kimberly G Blumenthal, MD, MSc (1) · Nicholas Paton (1)
U01AI184071 (1)